Trial
NCT02466074
Augmenting Cerebral Blood Flow to Treat Established Multiple Sclerosis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Health Science Center, Houston
Collaborators
—
Condition
Multiple Sclerosis
Intervention
Acetazolamide
Why stopped
Inadequate recruitment; termination of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-04-27